Sie befinden sich hier
Inhalt
The focus of our laboratory is to develop a comprehensive understanding of the molecular factors that drive the development of ovarian cancer and to develop new therapeutic approaches. Research over the last decade has led to the paradigm shift, showing that serous ovarian cancers originate in the secretory cells of the fallopian tube (FT) and not in the ovary. We are studying how genetic factors and the microenvironment can trigger the dissemination and metastasization of precursor lesions to the ovary and the peritoneum. To study those mechanisms we perform comprehensive analysis of primary tumor samples that were isolated from different metastatic sides using 3D organoid models. Additionally, we use immortalized FT cell lines and co-culture models to study the dissemination process.

Kontextspalte
Contact

Dr. Kai Doberstein
Experimentelle & Translationale Gynäkologische Onkologie
Frauenklinik
Universitätsmedizin Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Phone +49 621 383-2680
kai.doberstein@ medma.uni-heidelberg.de
Contact

Prof. Dr. Marc Sütterlin
Frauenklinik
Universitätsmedizin Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
marc.suetterlin@ umm.de
Contact

Prof. Dr. med. Frederik Marmé
Sektionsleitung Konservative Gynäkologische Onkologie
Experimentelle & Translationale Gynäkologische Onkologie
Medizinische Fakultät Mannheim
Universität Heidelberg
Frauenklinik
Universitätsmedizin Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Phone +49 621 383-8215
Phone +49 621 383-3661
Frederik.Marme@ umm.de